Roche obesity drug trial met main goals on glucose and weight

Roche Holding said its obesity drug candidate met the main objectives of a midstage clinical trial, helping patients reduce blood glucose and body weight, as it looks to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.